APA (7th ed.) Citation

Glasmacher, A., Hahn, C., Hoffmann, F., Naumann, R., Goldschmidt, H., Lilienfeld-Toal, M. v., . . . Gorschlüter, M. (2006). A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma. British journal of haematology, 132(5), . https://doi.org/10.1111/j.1365-2141.2005.05914.x

Chicago Style (17th ed.) Citation

Glasmacher, Axel, Corinna Hahn, Florian Hoffmann, Ralph Naumann, Hartmut Goldschmidt, Marie von Lilienfeld-Toal, Katjana Orlopp, Ingo Schmidt-Wolf, and Marcus Gorschlüter. "A Systematic Review of Phase-II Trials of Thalidomide Monotherapy in Patients with Relapsed or Refractory Multiple Myeloma." British Journal of Haematology 132, no. 5 (2006). https://doi.org/10.1111/j.1365-2141.2005.05914.x.

MLA (9th ed.) Citation

Glasmacher, Axel, et al. "A Systematic Review of Phase-II Trials of Thalidomide Monotherapy in Patients with Relapsed or Refractory Multiple Myeloma." British Journal of Haematology, vol. 132, no. 5, 2006, https://doi.org/10.1111/j.1365-2141.2005.05914.x.